Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/1989
04/25/1989US4824936 (19-Alanine) calcitonin
04/25/1989US4824861 Pyrrolidone derivatives and memory enhancement use thereof
04/25/1989US4824850 Dihydropyridine-pyridinium salt redox carrier
04/25/1989US4824674 Stable alpha-interferon dosage forms
04/25/1989CA1253299A1 Polypeptide and process for producing the same
04/25/1989CA1253297A1 Proline derivatives
04/25/1989CA1253072A1 Medications comprising tripeptides
04/25/1989CA1253071A1 Use of transforming growth factor to promote wound healing
04/24/1989EP0320507A4 Scaled-up production of liposome-encapsulated hemoglobin.
04/24/1989EP0302925A4 A method for producing factor viii in high yield.
04/24/1989EP0241539A4 Expression systems for overproduction of desired proteins.
04/20/1989WO1989003420A1 Anti-retroviral agent
04/20/1989WO1989003399A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
04/20/1989WO1989003397A1 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
04/20/1989WO1989003396A2 Antibodies to natural killer cell and non-specific cytotoxic cell receptor
04/20/1989WO1989003395A1 Receptor for natural killer and non-specific cytotoxic cells
04/20/1989WO1989003394A1 Antigen recognized by natural killer and non-specific cytotoxic cells
04/20/1989WO1989003393A1 Vasoactive peptides
04/20/1989WO1989003392A1 Polypeptides with type iv collagen activity
04/20/1989WO1989003225A1 Purification of monomeric interferon
04/20/1989WO1989003224A1 Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea
04/20/1989WO1989003222A1 Soluble human cd4 fragments and uses therefor
04/20/1989WO1989003221A1 Antisyncytial agent
04/20/1989WO1989003211A1 Treatment of cocaine addiction
04/20/1989WO1989003207A1 A drug composition with microspheres and process for its preparation
04/19/1989EP0312291A2 Di-or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA
04/19/1989EP0312283A2 Di-or tripeptide renin inhibitors containing lactam conformational restrictions in ACHPA
04/19/1989EP0312222A1 Treatment of diseases caused by viruses
04/19/1989EP0312208A1 Gel formulations containing growth factors
04/19/1989EP0312159A2 Method for producing hepatitis B virus proteins in yeast
04/19/1989EP0312158A2 Tetrapeptide renin inhibitors having novel c-terminal amino acid amide
04/19/1989EP0312157A2 Tetrapeptide renin inhibitors having a novel c-terminal amino acid
04/19/1989EP0312127A2 Glycosylated insulin derivatives
04/19/1989EP0312052A1 Intranasal administration of polypeptides in powdered form
04/19/1989EP0311950A2 Procedure for preparing a sterile plasme protein solution, which contains fibrinogen and coagulation factor XIII
04/19/1989EP0311866A1 Treatment of lipoprotein anomalies linked to cholesterol metabolism
04/19/1989EP0311675A1 Immunotherapeutic methods and compositions
04/18/1989US4822894 Pure cis enantiomers of fused pyrrole ring carboxylates
04/18/1989US4822872 Preferential adsorption of impurities on water insoluble carrier with amine or aldehyde ligands
04/18/1989US4822821 A-amino-or butryic acid, isomers, and/or insulin
04/18/1989US4822818 Antihypertensive agents
04/18/1989US4822776 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
04/18/1989US4822775 Phenyl substituted dipeptide amides
04/18/1989US4822774 Bronchodilator agent and hypotensive agent
04/18/1989US4822612 Anticancer agent
04/18/1989US4822608 Synergistic action with antibiotics
04/18/1989US4822606 Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
04/18/1989US4822605 Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
04/18/1989CA1252948A1 Process for purifying proteins
04/18/1989CA1252745A1 Antibiotic a26201-1 and antibiotic a26201-2 produced by a strain of actinoplanes
04/18/1989CA1252744A1 Ultrapurification of factor ix and other vitamin k- dependent proteins
04/18/1989CA1252721A1 Composition for prevention and treatment of mycoplasmal pneumonia
04/18/1989CA1252719A1 METHOD FOR THE PREPARATION OF CONJUGATES OF ADENINE-9- .beta.-ARABINOFURANOSIDE 5' MONOPHOSPHATE WITH LACTOSAMINATED HUMAN ALBUMIN, THE CONJUGATES OBTAINED AND THERAPEUTICALLY ACTIVE COMPOSITION CONTAINING THEM
04/18/1989CA1252718A1 Method of treating cerebral ischemia
04/18/1989CA1252717A1 Buffered polyol-hormone mixture for use in chronic parenteral hormone administration
04/12/1989EP0311589A1 Modified tissue plasminogen activator
04/12/1989EP0311438A2 Antigen capable of binding to cancer cells
04/12/1989EP0311194A2 Process for antifungal fermentation product and culture
04/12/1989EP0311193A2 Antifungal fermentation product
04/12/1989EP0311163A2 Use of site-specific modified lipolytic enzymes for the selective hydrolysis of organized lipid structures
04/12/1989EP0311012A2 Glaucoma treatment
04/12/1989EP0310918A2 Peptide-like amino-acid derivatives
04/12/1989EP0310887A2 Vasoconstrictor peptide
04/12/1989EP0310719A1 Method for purification of antibodies
04/12/1989EP0310639A1 Omega-3 fatty acids in traumatic injury treatment.
04/12/1989CN1032296A Synergistic interplay of lymphokines and dsrnas
04/11/1989US4821021 Selective calling radio display pager having a message recalling algorithm which simplifies operations
04/11/1989US4820834 Gastrin, cholecystokinin antagonists
04/11/1989US4820811 Amine reacted therapeutic agents
04/11/1989US4820804 Analogs of [1,7-di-alanine, des-19-leucine]calcitonin
04/11/1989US4820731 Parenteral dietary supplement and method of minimizing effects of infection through diet
04/11/1989US4820729 Hypotensive agents
04/11/1989US4820696 Modulation of aids virus-related events by double-stranded RNAS
04/11/1989US4820691 Hypotensive agents
04/11/1989US4820690 Duodenal and gastric ulcer treatment with oral urogastrone
04/11/1989US4820689 Pharmaceutical composition containing a glycoprotein
04/11/1989US4820641 Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
04/11/1989US4820516 Hyaluronidase
04/06/1989WO1989002922A1 Adheson variants
04/06/1989WO1989002915A1 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods
04/06/1989WO1989002899A1 Monoclonal antibody that recognizes an epitope of the gamma chain of human t cell surface receptors
04/06/1989WO1989002897A1 Therapeutic peptides
04/06/1989WO1989002751A1 Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
04/06/1989WO1989002750A1 Pharmaceutical compositions of recombinant beta-interferon and formulation processes
04/06/1989WO1989002748A1 Reduction of low density lipoproteins in biological fluids
04/06/1989WO1989002747A1 Therapeutic thrombolytic composition
04/06/1989WO1989002746A1 Uses of recombinant colony stimulating factor-1
04/06/1989WO1989002745A1 Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis
04/06/1989WO1989002744A1 Synergistic antifungal protein and compositions containing same
04/06/1989WO1989002734A1 Vasoconstrictive substances in combination with cytotoxic agents
04/06/1989WO1989001490A3 Biologically active molecules
04/05/1989EP0310585A2 Octapeptide inhibitors of myristoylating enzymes
04/05/1989EP0310476A1 Inhibitory or destructible composition of at least one unicellular living being containing fluor F- and lithium li+
04/05/1989EP0310410A2 Control of calcium activated potassium efflux from injured body cells
04/05/1989EP0310288A2 Improved ovulation treatment
04/05/1989EP0310238A2 New physiologically active substances, probestin and prostatin and production thereof
04/05/1989EP0310178A1 Recovery of pres2+S antigen
04/05/1989EP0310136A2 Macrophage-derived inflammatory mediator (MIP-1alpha and MIP-1beta)
04/05/1989EP0310065A2 Fibrinolytic activity enhancer
04/05/1989EP0310015A2 Renin-inhibiting dipeptides, process for their preparation, medicines containing them and their use
1 ... 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 ... 3163